Richard E. Lowenthal, President and CEO: ARS Pharmaceuticals SPRY Sell · Filed 24/06/13

Trade details

Type: Insider sale
Amount: $438,975.92
Shares · price: 48,028 sh · $9.14 a share
Held after: 1,698,499 sh
Stock: ARS Pharmaceuticals SPRY
Person: Richard E. LowenthalPresident and CEO
Trade date: 24/06/12
Filed: 24/06/13
Days to filing: 1 days

Sold 2.7% of holdings

Share of holding sold: 2.7%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/05/13~24/07/12

Richard E. Lowenthal's recent trades

Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$177K
35,000 sh
$177K
Filed 09/11
Traded 09/11
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$421.1K
75,000 sh
$421.1K
Filed 09/04
Traded 09/04
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$115.6K
19,805 sh
$115.6K
Filed 09/03
Traded 09/03
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$5,000
840 sh
$5,000
Filed 09/02
Traded 09/02
Richard E. LowenthalPresident and CEO
Planned saleARS Pharmaceuticals
Planned sale
ARS Pharmaceuticals
SPRY
$148.2K
25,000 sh
$148.2K
Filed 08/20
Traded 08/20

Richard E. Lowenthal, CEO — sold $439K of ARS Pharmaceuticals SPRY · 2.7% of holdings · 10b5-1 plan | Whalegun